Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
oral gavage twice daily for 2 days) exhibits fibrinolytic activity and dissolves blood clots in vivo
CH4O3S/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22
4″-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by Sensitive and Resistant P388 Leukemia Cells
and also in approved drugs products as its m-substituted analog known as neo-synephrine
Progesterone Size:Solid 2 mg oral gavage twice daily forAKT inhibitor VIII, also known as AKTi 1 2, is a potent, selective and ell permeable, allosteric inhibitor of Akt 1 and 2, which efficiently inhibits CaMKI activity and aryl hydrocarbon receptor pathway. AKT inhibitor VIII suppresses hyperthermia induced Ndrg2 phosphorylation in gastric cancer cells. AKT inhibitor VIII displays good selectivity against a panel of 70 other kinases with micromolar inhibition against some kinases, for example, calcium
US$ 10.00
US$ 33.00
US$ 38.29
US$ 16.47